Terms: = Pancreatic cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
80 results:
1. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
Katsuya Y; Yoshida T; Takashima A; Yonemori K; Ohba A; Yazaki S; Yagishita S; Nakahama H; Kobayashi O; Yanagida M; Irino Y; Hamada A; Yamamoto N
Int J Clin Oncol; 2024 Apr; 29(4):386-397. PubMed ID: 38381163
[TBL] [Abstract] [Full Text] [Related]
2. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
[TBL] [Abstract] [Full Text] [Related]
3. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
[TBL] [Abstract] [Full Text] [Related]
4. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.
Mangieri CW; Valenzuela CD; Solsky IB; Erali RA; Pardee T; Lima CMSR; Howerton R; Clark CJ; Shen P
J Surg Oncol; 2023 Oct; 128(5):844-850. PubMed ID: 37341164
[TBL] [Abstract] [Full Text] [Related]
6. Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
Sugita M; Yamazaki T; Alhomoud M; Martinet J; Latouche JB; Golden E; Boyer O; Van Besien K; Formenti SC; Galluzzi L; Guzman ML
Cell Death Dis; 2023 May; 14(5):305. PubMed ID: 37142568
[TBL] [Abstract] [Full Text] [Related]
7. The EMA Assessment of Asciminib for the treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
Tesileanu CMS; Michaleas S; Gonzalo Ruiz R; Mariz S; Fabriek BO; van Hennik PB; Dedorath J; Dekic B; Unkrig C; Brandt A; Koenig J; Enzmann H; Delgado J; Pignatti F
Oncologist; 2023 Jul; 28(7):628-632. PubMed ID: 37141403
[TBL] [Abstract] [Full Text] [Related]
8. Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Miyagahara T; Fujimori N; Ueda K; Takamatsu Y; Matsumoto K; Teramatsu K; Takaoka T; Suehiro Y; Shimokawa Y; Omori K; Niina Y; Tachibana Y; Akashi T; Oono T; Ogawa Y
Asia Pac J Clin Oncol; 2023 Aug; 19(4):533-541. PubMed ID: 36478079
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract] [Full Text] [Related]
10. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract] [Full Text] [Related]
11. Asciminib (Scemblix): A third-line treatment option for chronic myeloid leukemia in chronic phase with or without T315I mutation.
Monestime S; Al Sagheer T; Tadros M
Am J Health Syst Pharm; 2023 Jan; 80(2):36-43. PubMed ID: 36197958
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract] [Full Text] [Related]
13. Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
Kumstel S; Schreiber T; Goldstein L; Stenzel J; Lindner T; Joksch M; Zhang X; Wendt EHU; Schönrogge M; Krause B; Vollmar B; Zechner D
PLoS One; 2022; 17(4):e0266601. PubMed ID: 35452495
[TBL] [Abstract] [Full Text] [Related]
14. In Vitro and In Vivo Metabolism of a Novel Antimitochondrial cancer Metabolism Agent, CPI-613, in Rat and Human.
Reddy VB; Boteju L; Boteju A; Shen L; Kassahun K; Reddy N; Sheldon A; Luther S; Hu K
Drug Metab Dispos; 2022 Apr; 50(4):361-373. PubMed ID: 35086846
[TBL] [Abstract] [Full Text] [Related]
15. Controversial benefit of 5-fluorouracil/leucovorin-based adjuvant chemotherapy for ampullary cancer: a propensity score-matched analysis.
Kang J; Lee W; Shin J; Park Y; Kwon JW; Jun E; Song KB; Lee JH; Hwang DW; Park SY; Kim SC
Langenbecks Arch Surg; 2022 May; 407(3):1091-1097. PubMed ID: 35013798
[TBL] [Abstract] [Full Text] [Related]
16. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in pancreatic Ductal Adenocarcinoma: A Multicenter Study.
Shi Z; Ma C; Huang X; Cao D
J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
[TBL] [Abstract] [Full Text] [Related]
17. The effect of danusertib, an Aurora kinase inhibitor, onto the cytotoxicity, cell cycle and apoptosis in pancreatic ductal adenocarcinoma cells.
Kirbiyik IA; Ozcimen AA
J Cancer Res Ther; 2021; 17(6):1419-1424. PubMed ID: 34916372
[TBL] [Abstract] [Full Text] [Related]
18. Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?
Blair AB; Beckman RM; Habib JR; Griffin JF; Lafaro K; Burkhart RA; Burns W; Weiss MJ; Cameron JL; Wolfgang CL; He J
HPB (Oxford); 2022 May; 24(5):645-653. PubMed ID: 34610896
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results.
Pavel M; Ćwikła JB; Lombard-Bohas C; Borbath I; Shah T; Pape UF; Capdevila J; Panzuto F; Truong Thanh XM; Houchard A; Ruszniewski P
Eur J Cancer; 2021 Nov; 157():403-414. PubMed ID: 34597974
[TBL] [Abstract] [Full Text] [Related]
20. Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.
Blanc T; Meignan P; Vinit N; Ballouhey Q; Pio L; Capito C; Harte C; Vatta F; Galmiche-Rolland L; Minard V; Orbach D; Berteloot L; Muller C; Kohaut J; Broch A; Braik K; Binet A; Heloury Y; Fourcade L; Lardy H; Sarnacki S
Ann Surg Oncol; 2022 Feb; 29(2):1315-1326. PubMed ID: 34523002
[TBL] [Abstract] [Full Text] [Related]
[Next]
